Advocacy
for Prevention Science
Advocacy
for Prevention Science describes scientific advances
and principles which form a foundation for advocacy
for prevention science. The document provides a
list of specific actions and principles which SPR’s
board agrees are worthy of public policy advocacy.
This document, produced by SPR’s newly reconstituted
Advocacy Committee chaired by Bob Saltz, and initiated
by SPR’s incoming president, Tony Biglan,
provides guidance to the SPR board and SPR members
as the Society seeks to become more actively involved
in education and discussion with policy makers toward
the achievement of SPR’s mission.
Advocacy
for Prevention Science (click
here for the full document)
Community
Monitoring Systems
The
Board of the Society for Prevention Research has
focused on the monitoring of the well-being of children
and adolescents as one of its strategic goals. With
funding from the Robert Wood Johnson Foundation
and the National Institutes of Health that is coordinated
through the National Science Foundation, SPR has
been conducting a CMS project, led by Anthony Biglan,
along with Patricia Mrazek and David Hawkins.
Standards
of Evidence
The
Society for Prevention Research is committed to
the advancement of science-based prevention programs
and policies through empirical research. Increasingly,
decision-makers and prevention service providers
seek tested and efficacious or effective programs
and policies for possible implementation. However,
until now, somewhat different standards have been
used by different organizations seeking to identify
and list programs and policies that have been tested
and shown to be efficacious or effective. As part
of SPR's strategic plan, in 2003, the SPR Board
of Directors appointed a committee of prevention
scientists, chaired by Brian Flay, to determine
the requisite criteria that must be met for preventive
interventions to be judged tested and efficacious
or tested and effective. The Standards of Evidence
developed by this committee have been unanimously
adopted by the Board of Directors of SPR on April
12, 2004, as the standards which SPR asserts should
be met if a program or policy is to be called tested
and efficacious or tested and effective.
- Standards
of Evidence: Criteria for Efficacy, Effectiveness
and Dissemination (click
here for full document)
- The
journal article explicating SPR’s Standards
of Evidence and the reasoning behind those standards
has been accepted for publication in Prevention
Science. The article, written collectively by
SPR’s committee on standards of evidence
chaired by Brian Flay, is called Standards of
Evidence:Criteria for Efficacy, Effectiveness
and Dissemination, by Flay et al. The full article
is now available on
line here
and appears in print in the September, 2005 issue
of Prevention Science.
Braided
Funding
A
Case for Braided Prevention Research and Service
Funding was developed by an SPR task force chaired
by David Olds. This document makes a strong case
for the need for effectiveness trials and dissemination
research to further the advances of prevention science.
Further, it explains why and how collaborative funding
across institutes that fund research and agencies
that provide funding for preventive services could
advance both knowledge regarding effective preventive
interventions and the provision of evidence based
preventive services at a broader scale.
A Case for Braided Prevention Research
and Service Funding (click
here for full document)
SPR
MAPS II Type 2 Translational Research: Overview
and Definitions
Mapping Advances in
Prevention Science (MAPS) are multidisciplinary
task forces funded by the SPR conference grant from
the National Institutes of Health. They serve the
purpose of carrying momentum from exchanges on cutting-edge
subfields of prevention science at the annual conference
over to scientific activity between conferences,
in order to advance them more rapidly. They are
designed to: (1) foster promising, emerging areas
of prevention science warranting greater concentration
of scientific energy; (2) articulate an agenda to
move research forward in such emerging areas; and
(3) nurture the scientific leadership and capacity
required to make the advances. The first MAPS (I)
focuses on biological factors in prevention and
the second MAPS (II) addresses Type 2 translational
research.
The
first product of the SPR MAPS II Type 2 Translational
Research task force is the Type 2 Translational
Research: Overview and Definitions Document. The
definitions document, which has been approved by
the SPR board of directors, was distributed to the
SPR 2008 Annual Meeting attendees.
Type
2 Translational Research: Overview and Definitions
(PDF)
SPR
MAPS II Type 2 Translational Research: Position
Statement, A Call for Bold Action to Support Prevention
Programs and Policies To Achieve Greater Public
Health and Economic Impact
A
primary purpose of the SPR MAPS (Mapping Advances
in Prevention Science) is to foster the emerging
area of Type 2 translational research, in part through
advocacy for necessary policy change. A prior paper
produced by the MAPS Type 2 Translational Research
Task Force (Overview
and Definitions PDF) has articulated how this
type of research is critically important to the
realization of the enhanced public health and economic
impact. The recent National Academies of Science
report on prevention programs for youth underscores
this point, referencing imbalances in resource allocation,
misplaced policy priorities, and the benefits of
health and social policy better informed by prevention
science. SPR is well-positioned to assure these
benefits are realized and that evidence-based prevention
reaches those it could help. For these reasons,
our MAPS Task Force has produced a position statement
calling for four “bold actions” to achieve
greater public health and economic impact through
Type 2 translational research. We believe it is
especially timely in the context of the current
economic downturn and health care reform efforts.
Type
2 Translational Research Task Force: Position Statement,
A Call for Bold Action to Support Prevention Programs
and Policies To Achieve Greater Public Health and
Economic Impact (PDF)
Return
to Top |